• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国丽水致病性微生物BSL-2实验室管理中的合规问题及影响因素分析

Analysis of compliance issues and influencing factors in the management of BSL-2 laboratories for pathogenic microorganisms in Lishui, China.

作者信息

Cong Ying, Li Jinkai, Lou Dingshuo, Zhu Jianliang, Zhang Deyong, Cheng Dongqing, Chen Xiuying

机构信息

Lishui Center for Disease Control and Prevention, Lishui, China.

School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China.

出版信息

Front Bioeng Biotechnol. 2025 Aug 8;13:1637056. doi: 10.3389/fbioe.2025.1637056. eCollection 2025.

DOI:10.3389/fbioe.2025.1637056
PMID:40861857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12371245/
Abstract

BACKGROUND

The management of biosafety laboratories for pathogenic microorganisms is directly related to public health and the effectiveness of biological experiments. However, persistent non-compliance issues in biosafety level 2 (BSL-2) laboratory management remain a challenge. This study aimed to assess the quality control of BSL-2 laboratories for pathogenic microorganisms in Lishui.

METHODS

By combining the Biosafety Online Supervision Systems and on-site inspections, this study assessed the quality control of 73 medical institutions and the 128 biosafety laboratories under their management in Lishui.

RESULTS

The results discovered that the 73 medical institutions had low compliance rates in several fields: Responsibilities of the biosafety management (80.82%), development of system documentation (65.75%), risk assessment (84.56%), training of laboratory personnel (82.19%), and biosafety labeling (52.05%). Additionally, 128 laboratories had low pass rates for the access control management system (85.94%), hand/eye wash and shower stations (85.94%), and biosafety cabinet operations (89.06%).

CONCLUSION

This study demonstrates that future efforts should focus on strengthening laboratory personnel training and implementing biosafety management responsibilities to ensure safe and regulation-compliant operations in laboratories handling pathogenic microorganisms.

摘要

背景

病原微生物生物安全实验室的管理直接关系到公众健康和生物实验的有效性。然而,生物安全二级(BSL-2)实验室管理中持续存在的不符合规定问题仍然是一项挑战。本研究旨在评估丽水市病原微生物BSL-2实验室的质量控制情况。

方法

本研究通过结合生物安全在线监督系统和现场检查,对丽水市73家医疗机构及其管理的128个生物安全实验室的质量控制情况进行了评估。

结果

结果发现,73家医疗机构在几个方面的合规率较低:生物安全管理职责(80.82%)、体系文件制定(65.75%)、风险评估(84.56%)、实验室人员培训(82.19%)和生物安全标识(52.05%)。此外,128个实验室的门禁管理系统(85.94%)、洗眼/洗手和淋浴设施(85.94%)以及生物安全柜操作(89.06%)的合格率较低。

结论

本研究表明,未来应着重加强实验室人员培训并落实生物安全管理责任,以确保处理病原微生物的实验室安全且合规运行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1278/12371245/980456a02ca3/fbioe-13-1637056-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1278/12371245/4cea22f535ad/fbioe-13-1637056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1278/12371245/5bf733edecb3/fbioe-13-1637056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1278/12371245/980456a02ca3/fbioe-13-1637056-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1278/12371245/4cea22f535ad/fbioe-13-1637056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1278/12371245/5bf733edecb3/fbioe-13-1637056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1278/12371245/980456a02ca3/fbioe-13-1637056-g004.jpg

相似文献

1
Analysis of compliance issues and influencing factors in the management of BSL-2 laboratories for pathogenic microorganisms in Lishui, China.中国丽水致病性微生物BSL-2实验室管理中的合规问题及影响因素分析
Front Bioeng Biotechnol. 2025 Aug 8;13:1637056. doi: 10.3389/fbioe.2025.1637056. eCollection 2025.
2
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.
3
Mining and quantitative evaluation of the laboratory biosafety policy in China.中国实验室生物安全政策的挖掘与定量评估
PLoS One. 2025 Aug 12;20(8):e0328923. doi: 10.1371/journal.pone.0328923. eCollection 2025.
4
Biosafety Level 2 Training Programs at Institutions of Higher Learning in the United States.美国高等院校的生物安全二级培训项目
Appl Biosaf. 2025 Mar 7;30(1):36-44. doi: 10.1089/apb.2024.0024. eCollection 2025 Mar.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Accreditation through the eyes of nurse managers: an infinite staircase or a phenomenon that evaporates like water.护士长眼中的认证:是无尽的阶梯还是如流水般消逝的现象。
J Health Organ Manag. 2025 Jun 30. doi: 10.1108/JHOM-01-2025-0029.
7
Personnel exposure studies to multi-source diffusion of bioaerosols under biosafety laboratory - Level 2 plus operating conditions.在生物安全二级加强型实验室操作条件下,人员对生物气溶胶多源扩散的暴露研究。
J Hazard Mater. 2025 Sep 5;495:139076. doi: 10.1016/j.jhazmat.2025.139076. Epub 2025 Jun 26.
8
The study of biosafety risk identification and analysis for facilities in biosafety level 3 laboratories.三级生物安全实验室设施生物安全风险识别与分析研究
Front Cell Infect Microbiol. 2025 Aug 27;15:1658759. doi: 10.3389/fcimb.2025.1658759. eCollection 2025.
9
Effects of Interventions to Improve Access to Financial Services for Micro, Small, and Medium-Sized Enterprises in Low- and Middle-Income Countries: An Evidence and Gap Map.改善低收入和中等收入国家微型、小型和中型企业金融服务可及性的干预措施的效果:证据与差距图
Campbell Syst Rev. 2025 Sep 10;21(3):e70061. doi: 10.1002/cl2.70061. eCollection 2025 Sep.
10
Sexual Harassment and Prevention Training性骚扰与预防培训

本文引用的文献

1
The Biosafety Research Road Map: The Search for Evidence to Support Practices in Human and Veterinary Laboratories.生物安全研究路线图:寻找支持人类和兽医实验室实践的证据。
Appl Biosaf. 2023 Jun 1;28(2):64-71. doi: 10.1089/apb.2022.0040. Epub 2023 Jun 5.
2
Editorial: Insights in biosafety and biosecurity 2022: Novel developments, current challenges, and future perspectives.社论:2022年生物安全与生物安保洞察:新进展、当前挑战及未来展望
Front Bioeng Biotechnol. 2023 Jan 12;10:1118506. doi: 10.3389/fbioe.2022.1118506. eCollection 2022.
3
Effectiveness of international virtual training on biorisk management in the context of COVID-19.
新冠疫情背景下国际虚拟培训在生物风险管理方面的效果。
Front Public Health. 2022 Oct 11;10:888097. doi: 10.3389/fpubh.2022.888097. eCollection 2022.
4
Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.迈向生物安全与生物安保的更好治理:中国在医学生物技术立法方面的进展与展望
Front Bioeng Biotechnol. 2022 Jul 4;10:939295. doi: 10.3389/fbioe.2022.939295. eCollection 2022.
5
Establishing a biosafety plan for a flow cytometry shared resource laboratory.建立流式细胞术共享资源实验室的生物安全计划。
Cytometry A. 2022 May;101(5):380-386. doi: 10.1002/cyto.a.24524. Epub 2022 Jan 17.
6
Drone transport of biological samples: an open issue.生物样本的无人机运输:一个悬而未决的问题。
Clin Chem Lab Med. 2021 Jul 27;59(11):1745-1746. doi: 10.1515/cclm-2021-0811.
7
China's evolving biosafety/biosecurity legislations.中国不断发展的生物安全/生物安保立法。
J Law Biosci. 2021 Jun 30;8(1):lsab020. doi: 10.1093/jlb/lsab020. eCollection 2021 Jan-Jun.
8
SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector.低收入和中等收入国家的新型冠状病毒2检测:私立卫生部门的可及性与可负担性
Microbes Infect. 2020 Nov-Dec;22(10):511-514. doi: 10.1016/j.micinf.2020.10.005. Epub 2020 Oct 14.
9
Biosafety and Biosecurity Challenges Facing Veterinary Diagnostic Laboratories in Lower-Middle Income Countries in Southeast Asia: A Case Study of Thailand.东南亚中低收入国家兽医诊断实验室面临的生物安全和生物安保挑战:以泰国为例
Appl Biosaf. 2019 Dec;24(4):220-230. doi: 10.1177/1535676019869771. Epub 2019 Aug 19.
10
A Post-donation Survey to Assess the Appropriateness of Medical Supply Donations to Freetown, Sierra Leone Following the Ebola Crisis.一项捐赠后调查,以评估埃博拉危机后向塞拉利昂弗里敦捐赠医疗用品的适宜性。
Cureus. 2020 Mar 9;12(3):e7228. doi: 10.7759/cureus.7228.